ADOCIA ANNOUNCES PATENTING STABLE COMBINATIONS OF GLP-1 AND AMYLIN ANALOGS FOR THE TREATMENT OF OBESITY AND DIABETES USING ITS BIOCHAPERONE® PLATFORM

Reuters · 10/15 06:00

Please log in to view news